Overview PF-04191834 Single Dose Bronchodilatory Study In Asthma. Status: Completed Trial end date: 2009-07-01 Target enrollment: Participant gender: Summary Study to determine the bronchodilatory effects of PF-04191834 compared with zileuton in patients with asthma Phase: Phase 2 Details Lead Sponsor: PfizerTreatments: Zileuton